Common bile duct stenting treatment in patient with CBD stones and multiple gallbladder stones

Comparison the therapeutical outcomes between common bile duct (CBD) stenting and standard endoscopic treatment in patient with CBD stones and multiple gallbladder stones

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161205031252N9

Enrollment

Registered

2018-09-22

Start date

2018-09-23

Completion date

Unknown

Last updated

2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common bile duct stones. Cholelithiasis

Interventions

Intervention 1: Intervention group: Common bile duct stenting. Intervention 2: Control group: Standard Endoscopic retrograde cholangiopancreatography.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with CBD stones and multiple gallbladder stones

Exclusion criteria

Exclusion criteria: History of bile duct surgery History of stomach and duodenal surgery History of cholecystectomy High risk for cardiovascular and respiratory events Bleeding disorders Radiotherapy history

Design outcomes

Primary

Measure	Time frame
Stone migration from gallbladder to common bile duct. Timepoint: 1 month after treatment. Method of measurement: Endoscopic retrograde cholangiopancreatography.	—

Secondary

Measure	Time frame
Chollangitis. Timepoint: After endoscopic retrograde cholangiopancreatography. Method of measurement: According to Charcot's triad including abdominal pain, serum bilirubin measurement and core body temperature measurement.;Pancreatitis. Timepoint: After endoscopic retrograde cholangiopancreatography. Method of measurement: Serum Amylase level measurement.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Hormati

Ghoum University of Medical Sciences

hormatia@yahoo.com+98 25 3612 2053

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026